18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas

Journal of Nuclear Medicine

Volumn 54, Issue 7, 2013, Pages 1120-1126

  Sai, Kiran Kumar Solingapuram ^a   Huang, Chaofeng ^a   Yuan, Liya ^b   Zhou, Dong ^a   Piwnica Worms, David ^a,b   Garbow, Joel R ^a   Engelbach, John A ^a   Mach, Robert H ^a   Rich, Keith M ^b   Mcconathy, Jonathan ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

18F; Amino acid; Click reaction; Glioma

Indexed keywords

2 AMINO 3 [1 (2 18F FLUOROETHYL) 1H [1,2,3]TRIAZOL 4 YL]PROPANOIC ACID FLUORODEOXYGLUCOSE F 18; FLUORODEOXYGLUCOSE F 18; O (2 18F FLUOROETHYL) LEVO TYROSINE FLUORODEOXYGLUCOSE F 18; TRACER; UNCLASSIFIED DRUG; (18F)FLUOROETHYLTYROSINE; 2 AMINO 3 (1 (2 FLUOROETHYL) 1H (1,2,3)TRIAZOL 4 YL)PROPANOIC ACID; 2-AMINO-3-(1-(2-FLUOROETHYL)-1H-(1,2,3)TRIAZOL-4-YL)PROPANOIC ACID; ALANINE; AMINO ACID; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE 18; RADIOPHARMACEUTICAL AGENT; TRIAZOLE DERIVATIVE; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MUSCLE LEVEL; DRUG STRUCTURE; DRUG TUMOR LEVEL; DRUG UPTAKE; GLIOBLASTOMA; IMAGE ANALYSIS; MALE; MOUSE; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STRUCTURE ANALYSIS; TUMOR XENOGRAFT; ANIMAL; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; BRAIN TUMOR; CLICK REACTION; COMPARATIVE STUDY; GLIOMA; METABOLIC CLEARANCE RATE; METABOLISM; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TUMOR CELL LINE;

18F; AMINO ACID; CLICK REACTION; GLIOMA;

ALANINE; ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; FLUORODEOXYGLUCOSE F18; GLIOMA; MALE; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED BALB C; ORGAN SPECIFICITY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TRIAZOLES; TYROSINE;

EID: 84879917290     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.113217     Document Type: Article

References (39)

1. Kaschten B, Stevenaert A, Sadzot B, et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med. 1998;39:778-785.
2. Cook GJR, Maisey MN, Fogelman I. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med. 1999;26:1363-1378.
3. Lau EWF, Drummond KJ, Ware RE, et al. Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumour. J Clin Neurosci. 2010;17:43-49.
4. Ogawa T, Inugami A, Hatazawa J, et al. Clinical positron emission tomography for brain tumors: comparison of [18F]-fluorodeoxyglucose and L-methyl-11Cmethionine. AJNR. 1996;17:345-353.
5. Weber WA, Wester H-J, Grosu AL, et al. O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med. 2000;27:542-549.
6. Floeth FW, Pauleit D, Wittsack H-J, et al. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-l- tyrosine and magnetic resonance spectroscopy. J Neurosurg. 2005;102:318-327.
7. Pauleit D, Floeth F, Hamacher K, et al. O-(2-[18F]fluoroethyl)-l-tyrosine PET combined with MR imaging improves the diagnostic assessment of cerebral gliomas. Brain. 2005;128:678-687.
8. Pöpperl G, Götz C, RachingerW, Gildehaus F-J, Tonn J-C, Tatsch K. Value of O- (2-[18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging. 2004;31:1464-1470.
9. Pöpperl G, Kreth FW, Herms J, et al. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J Nucl Med. 2006;47:393-403.
10. Weckesser M, Langen KJ, Rickert CH, et al. O-(2-[18F]fluorethyl)-L- tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging. 2005;32:422-429.
11. Lieberman BP, Ploessl K, Wang L, et al. PET imaging of glutaminolysis in tumors by 18F-(2S,4R)-4-fluoroglutamine. J Nucl Med. 2011;52:1947-1955.
12. Laverman P, Boerman OC, Corstens FH, Oyen WJ. Fluorinated amino acids for tumour imaging with positron emission tomography. Eur J Nucl Med Mol Imaging. 2002;29:681-690.
13. Sutinen E, Jyrkkiö S, Alanen K, Nagren K, Minn H. Uptake of [N-methyl-11C]amethylaminoisobutyric acid in untreated head and neck cancer studied by PET. Eur J Nucl Med Mol Imaging. 2003;30:72-77.
14. Uchino H, Kanai Y, Kim DK, et al. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol Pharmacol. 2002;61:729-737.
15. Fuchs BC, Bode BP. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol. 2005;15:254-266.
16. Nawashiro H, Otani N, Shinomiya N, et al. L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. Int J Cancer. 2006;119: 484-492.
17. Qu W, Oya S, Lieberman BP, et al. Preparation and characterization of L-[5-11C]- glutamine for metabolic imaging of tumors. J Nucl Med. 2012;53:98-105.
18. Qu W, Zha Z, Ploessl K, et al. Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors. J Am Chem Soc. 2011;133:1122-1133.
19. QuW, ZhaZ,LiebermanBP, et al. Facile synthesis [5-(13)C-4-(2)H(2)]-L- glutamine for hyperpolarized MRS imaging of cancer cell metabolism. Acad Radiol. 2011;18:932-939.
20. Krasikova RN, Kuznetsova OF, Fedorova OS, et al. 4-[18F]fluoroglutamic acid (BAY 85-8050), a new amino acid radiotracer for PET imaging of tumors: synthesis and in vitro characterization. J Med Chem. 2011;54:406-410.
21. McConathy J, Martarello L, Malveaux EJ, et al. Radiolabeled amino acids for tumor imaging with PET:radiosynthesis and biological evaluation of 2-Amino-3- [18F]fluoro-2-methylpropanoic acid and 3-[18F]fluoro-2-methyl-2- (methylamino) propanoic acid. J Med Chem. 2002;45:2240-2249.
22. McConathy J, Zhou D, Shockley SE, et al. Click synthesis and biologic evaluation of (R)- and (S)-2-amino-3-[1-(2-[18F]fluoroethyl)-1H-[1,2,3]triazol- 4-yl] propanoic acid for brain tumor imaging with positron emission tomography. Mol Imaging. 2010;9:329-342.
23. McConathy J, Martarello L, Malveaux EJ, et al. Synthesis and evaluation of 2- amino-4-[18F]fluoro-2-methylbutanoic acid (FAMB): relationship of amino acid transport to tumor imaging properties of branched fluorinated amino acids. Nucl Med Biol. 2003;30:477-490.
24. Yu W, McConathy J, Olson J, Camp VM, Goodman MM. Facile stereospecific synthesis and biological evaluation of (S)- and (R)-2-amino-2-methyl-4-[123I] iodo-3-(E)-butenoic acid for brain tumor imaging with single photon emission computerized tomography. J Med Chem. 2007;50:6718-6721.
25. Gupta N, Prasad PD, Ghamande S, et al. Up-regulation of the amino acid transporter ATB(0,1) (SLC6A14) in carcinoma of the cervix. Gynecol Oncol. 2006;100:8-13.
26. Gupta N, Miyauchi S, Martindale RG, et al. Upregulation of the amino acid transporter ATB0,1 (SLC6A14) in colorectal cancer and metastasis in humans. Biochim Biophys Acta. 2005;1741:215-223.
27. O'Kane RL, Vina JR, Simpson I, Zaragoza R, Mokashi A, Hawkins RA. Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y1. Am J Physiol Endocrinol Metab. 2006;291:E412-E419.
28. Dillon BJ, Prieto VG, Curley SA, et al. Incidence and distribution of argininosuccinate synthetase deficiency in human cancers. Cancer. 2004;100:826-833.
29. Yang TS, Lu SN, Chao Y, et al. A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients. Br J Cancer. Aug 31 2010.
30. Jost SC, Wanebo JE, Song S-K, et al. In vivo imaging in a murine model of glioblastoma. Neurosurgery. 2007;60:360-370.
31. Tang G, Tang X, Wang M, Luo L, Gan M, Huang Z. Automated commercial synthesis system for preparation of O-(2-[18F]fluoroethyl)-L-tyrosine by direct nucleophilic displacement on a resin column. J Labelled Comp Radiopharm. 2003;46:661-668.
32. Zuhayra M, Alfteimi A, Forstner CV, Lützen U, Meller B, Henze E. New approach for the synthesis of [18F]fluoroethyltyrosine for cancer imaging: simple, fast, and high yielding automated synthesis. Bioorg Med Chem. 2009;17:7441-7448.
33. Gazzola GC, Dall'Asta V, Franchi-Gazzola R, White MF. The cluster-tray method for rapid measurement of solute fluxes in adherent cultured cells. Anal Biochem. 1981;115:368-374.
34. Mourad PD, Farrell L, Stamps LD, Chicoine MR, Silbergeld DL. Why are systemic glioblastoma metastases rare? Systemic and cerebral growth of mouse glioblastoma. Surg Neurol. 2005;63:511-519.
35. Jost SC, Collins L, Travers S, Piwnica-Worms D, Garbow Jr. Measuring brain tumor growth: combined bioluminescence imaging-magnetic resonance imaging strategy. Mol Imaging. 2009;8:245-253.
36. Langen K-J, Hamacher K,Weckesser M, et al. O-(2-[18F]fluoroethyl)-L- tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol. 2006;33:287-294.
37. Tsukada H, Sato K, Fukumoto D, Nishiyama S, Harada N, Kakiuchi T. Evaluation of d-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with l- and d-11Cmethionine. J Nucl Med. 2006;47:679-688.
38. Hatzoglou M, Fernandez J, Yaman I, Closs E. Regulation of cationic amino acid transport: the story of the CAT-1 transporter. Annu Rev Nutr. 2004;24:377-399.
39. Oldendorf WH. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol. 1971;221:1629-1639.